Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway

被引:8
|
作者
Li, Cuiping [1 ,2 ,3 ]
Guo, Hejia [4 ]
Xiong, Juan [5 ]
Feng, Binghua [1 ]
Zhu, Peiqi [1 ]
Jiang, Weidong [1 ]
Jiang, Panpan [6 ]
Su, Xiaoping [1 ,2 ,3 ]
Huang, Xuanping [1 ,2 ]
机构
[1] Guangxi Med Univ, Affiliated Stomatol Hosp, Coll Stomatol, Nanning 530021, Peoples R China
[2] Guangxi Key Lab Rehabil & Reconstruct Oral & Maxil, Nanning 530021, Peoples R China
[3] Guangxi Hlth Commiss Key Lab prevent & treatment o, Nanning 530021, Peoples R China
[4] Zhejiang Univ, Canc Ctr, Stomatol Hosp, Zhejiang Prov Clin Res Ctr Oral Dis,Key Lab Oral B, Hangzhou 310000, Peoples R China
[5] Shenzhen Univ, Hlth Sci Ctr, Sch Publ Hlth, Shenzhen 518061, Peoples R China
[6] Shenzhen Aone Med Lab Co Ltd, Shenzhen 518000, Peoples R China
关键词
Exosomes; Long noncoding RNAs; Oral squamous cell carcinoma; PI3K-AKT-mTOR pathway; BIOMARKERS; RECURRENCE;
D O I
10.1016/j.prp.2022.154219
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Long noncoding RNAs (lncRNAs) are essential and critical components of signal and transduction, regulating the intracellular microenvironment. Serum exosomes (SEs) are involved in rearranging the intercel-lular functional lncRNAs, which may also play a role in oral squamous cell carcinoma (OSCC). The function of lncRNAs at the transcription level in SEs of patients with OSCC is partially understood.Materials and methods: The lncRNA expression profiles were examined derived from SEs from patients with OSCC with lymph node metastasis (OSCC-LNM), OSCC with no LNM (OSCC-NLNM), postoperative metastasis and recurrence OSCC (rOSCC) and healthy controls (HCs). Bioinformatics analysis was used to analyse differentially expressed lncRNAs (DE lncRNAs) and a total of 150 subjects were enrolled for RT-PCR verifications. The cor-relations of four lncRNAs and clinicopathologic factors, biochemical indexes were evaluated. MAGI2-AS3 and CCDC144NL-AS1 were overexpressed or silenced in oral cancer (OC) cells. The proliferation, invasion, and migration were evaluated to investigate the effect of MAGI2-AS3 and CCDC144NL-AS1 on the development of OSCC. The related proteins of PI3K-AKT-mTOR signal pathway were also detected.Results: The expressions of the lncRNAs, namely MAGI2-AS3 and CCDC144NL-AS1, were significantly upregu-lated in rOSCC and OSCC-LNM. MAGI2-AS3 was overexpressed in cancer tissue compared to other control groups. AC109587.1 and AC010978.1 were significantly associated with the clinical stage, and CCDC144NL-AS1 was significantly associated with aging. MAGI2-AS3 and CCDC144NL-AS1 might promote cell proliferation, invasion, and migration in OSCC cells by regulating the PI3K-AKT-mTOR pathway.Conclusions: our results suggest that MAGI2-AS3 an d CCDC144NL-AS1 may have clinical applications in the treatment of OSCC.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Upregulation of exosomal integrin β4 causes osteosarcoma cell proliferation via the PI3K-Akt-mTOR signaling pathway
    Wang, Qianrong
    Shi, Zheughua
    Zhang, Hongmei
    Liu, Wenchao
    Yu, Zhicao
    Zhau, Qiong
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (05) : 1209 - 1220
  • [2] Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K/AKT/mTOR signaling pathway
    Ma, Lei
    Huang, Ke
    Zhang, Haibo
    Kim, Eungyung
    Kim, Hyeonjin
    Liu, Zhibin
    Kim, Chae Yeon
    Park, Kanghyun
    Raza, Muhammad Atif
    Kim, Kirim
    Yi, Junkoo
    Sung, Yonghun
    Ryoo, Zae Young
    Kim, Yong-Gun
    Kim, Myoung Ok
    JOURNAL OF CANCER, 2024, 15 (03): : 659 - 670
  • [3] LINC02154 Promotes Esophageal Squamous Cell Carcinoma Progression via the PI3K-AKT-mTOR Signaling Pathway by Interacting With IGF2BP2
    Zhang, Mingyuan
    Zhang, Cai
    Zhou, Fuyou
    Yang, Ruotong
    Feng, Yang
    Ji, Yangyang
    Ren, Huijun
    Ming, Liang
    MOLECULAR CARCINOGENESIS, 2025,
  • [4] Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy
    Wu, You-Tong
    Tan, Hui-Ling
    Huang, Qing
    Ong, Choon-Nam
    Shen, Han-Ming
    AUTOPHAGY, 2009, 5 (06) : 824 - 834
  • [5] PI3K-AKT-MTOR PATHWAY IN PENILE SQUAMOUS CELL CARCINOMA: CLINICAL SIGNIFICANCE OF PTEN, AKT AND S6 EXPRESSION
    Azizi, Mounsif
    Tang, Dominic H.
    Verduzco, Daniel
    Chipollini, Juan
    Peyton, Charles C.
    Zhou, Jun-Min
    Schaible, Braydon
    Dhillon, Jasreman
    Spiess, Philippe E.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E497 - E497
  • [6] Effects of LAIR-1 on hepatocellular carcinoma cell proliferation and invasion via PI3K-AKT-mTOR pathway regulation
    Zhou, Ti
    Liu, Luqing
    Lan, Haibin
    Fang, Donglin
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (08)
  • [7] Knockdown of Metadherin suppressed the progression of oral squamous cell carcinoma via PI3K/AKT signaling pathway
    Ding, Z. Y.
    Dong, G.
    Yin, G.
    Yu, L. L.
    Li, W. X.
    Ding, B.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (01): : 303 - 309
  • [8] Aluminum-Induced Synaptic Plasticity Impairment via PI3K-Akt-mTOR Signaling Pathway
    Huan Li
    Xingli Xue
    Liang Li
    Yaqin Li
    Yanni Wang
    Tao Huang
    Yanhong Wang
    Huaxing Meng
    Baolong Pan
    Qiao Niu
    Neurotoxicity Research, 2020, 37 : 996 - 1008
  • [9] Ziprasidone triggers inflammasome signaling via PI3K-Akt-mTOR pathway to promote atrial fibrillation
    Lu, Ming-Kun
    Huo, Yen-Nien
    Tai, Buh-Yuan
    Lin, Chih-Yuan
    Yang, Hsiang-Yu
    Tsai, Chien-Sung
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [10] Unveiling the nexus: Long non-coding RNAs and the PI3K/Akt pathway in oral squamous cell carcinoma
    Pathoor, Naji Naseef
    Ganesh, Pitchaipillai Sankar
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262